Intensity Therapeutics Inc.
INTS | NASDAQ
$3.90
-$0.12 (-2.99%)
Sep 22, 2026, 12:19 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 7K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6K | n/a | n/a | 38.62K | 100.47K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -7K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6K | n/a | n/a | -38.62K | -100.47K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -3.08M | -2.53M | -3.14M | -2.73M | -2.71M | -3.39M | -3.2M | -3.57M | -5.07M | -4.74M | -3.35M | -2.49M | -1.22M | -1.25M | -1.56M | -1.77M | -1.93M | -2.38M | -2.41M | -2.14M | -1.96M | -1.5M |
Interest Income | 77K | 94K | 88K | 59K | 17K | 15K | 28K | 48K | 98K | 140K | 175.97K | 147.54K | 171 | 316 | 637 | 988 | 213 | 643 | 348 | 647 | 875 | 739 |
Pretax Income | -3.01M | -2.43M | -3.05M | -2.67M | -2.54M | -3.35M | -3.18M | -3.51M | -4.97M | -4.6M | -3.17M | -2.33M | -3.7M | -1.34M | -1.51M | -1.77M | -1.93M | -2.37M | -2.4M | -2.12M | -1.89M | -1.48M |
Net Income | -3.01M | -2.43M | -3.05M | -2.67M | -2.54M | -3.35M | -3.18M | -3.51M | -4.97M | -4.6M | -3.17M | -2.33M | -3.7M | -1.34M | -1.51M | -1.77M | -1.93M | -2.37M | -2.4M | -2.12M | -1.89M | -1.48M |
Selling & General & Admin | 1.25M | 1.33M | 1.64M | 1.18M | 1.16M | 1.21M | 1.24M | 1.42M | 1.51M | 1.92M | 1.55M | 1.14M | 323.87K | 379.88K | 584.03K | 607.11K | 543.83K | 684K | 972.67K | 639.46K | 261.05K | 284.04K |
Research & Development | 1.83M | 1.2M | 1.5M | 1.55M | 1.54M | 2.19M | 1.97M | 2.15M | 3.56M | 2.82M | 1.8M | 1.35M | 859.21K | 773.77K | 891.11K | 1.16M | 1.39M | 1.69M | 1.44M | 1.5M | 1.7M | 1.22M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 80.71K | n/a | n/a | 23 | n/a | n/a | n/a | n/a |
Operating Expenses | 3.08M | 2.53M | 3.14M | 2.73M | 2.71M | 3.39M | 3.2M | 3.57M | 5.07M | 4.74M | 3.35M | 2.49M | 1.18M | 1.15M | 1.56M | 1.77M | 1.93M | 2.38M | 2.41M | 2.14M | 1.96M | 1.5M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 221.78K | 83.38K | 36.9K | 15.12K | 14.96K | 14.8K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.08M | 2.53M | 3.14M | 2.73M | 2.71M | 3.39M | 3.2M | 3.57M | 5.07M | 4.74M | 3.35M | 2.49M | 1.22M | 1.25M | 1.56M | 1.77M | 1.93M | 2.38M | 2.41M | 2.14M | 1.96M | 1.5M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 356 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 27.07M | 25.34M | 13.56M | 1.72M | 754.72K | 606.92K | 576K | 552.16K | 548.48K | 548.36K | 550.6K | 546.4K | 103.6K | 136.4K | 136.4K | 136.4K | 136.4K | 136.4K | 136.4K | 136.4K | 136.4K | 136.4K |
Shares Outstanding (Diluted) | 27.07M | 25.34M | 13.56M | 1.72M | 754.72K | 606.93K | 576.04K | 552.19K | 548.49K | 548.38K | 550.61K | 546.43K | 140.66K | 136.4K | 136.4K | 136.4K | 136.4K | 136.4K | 136.4K | 136.4K | 136.4K | 136.4K |
EPS (Basic) | -1.11 | -0.96 | -1.21 | -1.55 | -3.25 | -5.50 | -5.50 | -6.25 | -9 | -8.50 | -5.75 | -4.25 | -35.75 | -9.75 | -11 | -13 | -14.25 | -17.25 | -17.50 | -15.50 | -13.75 | -10.75 |
EPS (Diluted) | -1.11 | -0.96 | -1.21 | -1.55 | -3.25 | -5.50 | -5.50 | -6.25 | -9 | -8.50 | -5.75 | -4.25 | -35.75 | -9.75 | -11 | -13 | -14.25 | -17.25 | -17.50 | -15.50 | -13.75 | -10.75 |
EBITDA | -3.08M | -2.43M | -3.05M | 62K | -2.54M | -3.34M | -3.18M | -3.51M | -4.97M | -4.6M | -3.17M | -2.33M | -3.44M | -1.15M | -1.43M | -1.71M | -1.87M | -2.31M | -2.4M | -2.12M | -1.84M | -1.46M |
EBIT | -3.08M | -2.43M | -3.05M | -2.67M | -2.54M | -3.35M | -3.18M | -3.51M | -4.97M | -4.6M | -3.17M | -2.33M | -3.48M | -1.25M | -1.47M | -1.76M | -1.91M | -2.35M | -2.4M | -2.12M | -1.89M | -1.5M |
Depreciation & Amortization | n/a | n/a | 6K | 2.73M | n/a | 6K | n/a | 7K | 6K | 6K | 5.89K | 2.02K | 38.62K | 100.47K | 45.43K | 44.98K | 44.53K | 44.09K | n/a | n/a | 55.81K | 42.4K |
Add to Watchlist
Select watchlists to add or remove INTS